Annual Accounts Receivable
N/A
31 December 2023
Summary:
ProMIS Neurosciences annual accounts receivable is not available.PMN Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
N/A
30 September 2024
Summary:
ProMIS Neurosciences quarterly accounts receivable is not available.PMN Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PMN Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
PMN Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time |
ProMIS Neurosciences Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $100.80 K(-39.4%) |
| Sept 2021 | - | $166.30 K(+202.4%) |
| June 2021 | - | $55.00 K(-71.0%) |
| Mar 2021 | - | $189.40 K(+320.9%) |
| Sept 2020 | - | $45.00 K(+53.1%) |
| June 2020 | - | $29.40 K(-40.0%) |
| Mar 2020 | - | $49.00 K(+2478.9%) |
| Mar 2016 | - | $1900.00(-66.7%) |
| Sept 2015 | - | $5700.00(+714.3%) |
| June 2015 | - | $700.00(>+9900.0%) |
| Mar 2015 | - | $0.00(0.0%) |
| Dec 2014 | $600.00(-99.7%) | - |
| Sept 2014 | - | $0.00(-100.0%) |
| June 2014 | - | $39.50 K(-80.0%) |
| Mar 2014 | $197.60 K(+5388.9%) | $197.60 K(>+9900.0%) |
| Dec 2013 | - | $600.00(0.0%) |
| Sept 2013 | - | $600.00(-95.7%) |
| June 2013 | - | $13.90 K(+286.1%) |
| Mar 2013 | $3600.00(-96.3%) | $3600.00(-89.0%) |
| Sept 2012 | - | $32.70 K(-31.4%) |
| June 2012 | - | $47.70 K(+16.3%) |
| Dec 2011 | - | $41.00 K(-4.2%) |
| Sept 2011 | - | $42.80 K(-41.9%) |
| June 2011 | - | $73.70 K(-24.6%) |
| Mar 2011 | $97.80 K | $97.80 K(+60.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2010 | - | $61.00 K(-33.6%) |
| Sept 2010 | - | $91.90 K(-31.9%) |
| June 2010 | - | $134.90 K(+9.1%) |
| Mar 2010 | $123.60 K(+196.4%) | $123.60 K(-25.3%) |
| Dec 2009 | - | $165.40 K(+123.2%) |
| Sept 2009 | - | $74.10 K(+93.0%) |
| June 2009 | - | $38.40 K(-7.9%) |
| Mar 2009 | $41.70 K(-78.3%) | $41.70 K(-35.1%) |
| Dec 2008 | - | $64.30 K(-26.8%) |
| Sept 2008 | - | $87.80 K(-57.3%) |
| June 2008 | - | $205.50 K(+6.8%) |
| Mar 2008 | $192.40 K(-3.4%) | $192.40 K(+70.6%) |
| Dec 2007 | - | $112.80 K(+32.7%) |
| Sept 2007 | - | $85.00 K(-67.8%) |
| June 2007 | - | $263.80 K(+32.5%) |
| Mar 2007 | $199.10 K(+188.6%) | $199.10 K(+58.5%) |
| Dec 2006 | - | $125.60 K(+11.6%) |
| Sept 2006 | - | $112.50 K(+20.1%) |
| June 2006 | - | $93.70 K(+35.8%) |
| Mar 2006 | $69.00 K | $69.00 K(-5.9%) |
| Dec 2005 | - | $73.30 K(+63.6%) |
| Sept 2005 | - | $44.80 K(+189.0%) |
| June 2005 | - | $15.50 K(+112.3%) |
| Dec 2002 | - | $7300.00(+25.9%) |
| Dec 2001 | - | $5800.00(-86.8%) |
| Dec 2000 | - | $43.90 K |
FAQ
- What is the all time high annual accounts receivable for ProMIS Neurosciences?
- What is the all time high quarterly accounts receivable for ProMIS Neurosciences?
What is the all time high annual accounts receivable for ProMIS Neurosciences?
ProMIS Neurosciences all-time high annual accounts receivable is $199.10 K
What is the all time high quarterly accounts receivable for ProMIS Neurosciences?
ProMIS Neurosciences all-time high quarterly accounts receivable is $263.80 K